Literature DB >> 20127448

Premenstrual dysphoric disorder: out of the appendix.

Teri Pearlstein1.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20127448     DOI： 10.1007/s00737-009-0111-4

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN： 1434-1816            Impact factor:   3.633


× No keyword cloud information.
  4 in total

1.  S-norfluoxetine microinfused into the basolateral amygdala increases allopregnanolone levels and reduces aggression in socially isolated mice.

Authors:  Marianela Nelson; Graziano Pinna
Journal:  Neuropharmacology       Date:  2010-10-29       Impact factor: 5.250

Review 2.  Up-regulation of neurosteroid biosynthesis as a pharmacological strategy to improve behavioural deficits in a putative mouse model of post-traumatic stress disorder.

Authors:  Graziano Pinna; Ann M Rasmusson
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

3.  Premenstrual dysphoric disorder: evidence for a new category for DSM-5.

Authors:  C Neill Epperson; Meir Steiner; S Ann Hartlage; Elias Eriksson; Peter J Schmidt; Ian Jones; Kimberly A Yonkers
Journal:  Am J Psychiatry       Date:  2012-05       Impact factor: 18.112

4.  Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression.

Authors:  Mauricio Schüler Nin; Luis A Martinez; Fabio Pibiri; Marianela Nelson; Graziano Pinna
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-21       Impact factor: 5.555
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.